Binal Maharaja
Psychiatry · Chicago, ILNPI 1508110990
Payments from drug & device makers
Across 392 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$670
- Johnson & Johnson$641
- Bausch Health US, LLC$405
- plus $2K from 23 others
What the payments were for
- Food & beverage$7,927100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 85 | $1,359 |
| AbbVie(2 entities) | 72 | $1,333 |
| Otsuka America Pharmaceutical, Inc. | 45 | $1,135 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $670 |
| Johnson & Johnson | 27 | $641 |
| Bausch Health US, LLC | 20 | $405 |
| Lundbeck LLC | 23 | $377 |
| Vanda Pharmaceuticals Inc. | 11 | $295 |
| Neos Therapeutics, LP | 13 | $266 |
| Teva Pharmaceuticals USA, Inc. | 6 | $261 |
| E.r. Squibb & Sons, L.L.C. | 11 | $184 |
| Sunovion Pharmaceuticals Inc. | 10 | $134 |
| Supernus Pharmaceuticals, Inc. | 4 | $107 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Eisai Inc. | 5 | $75 |
| Shire North American Group Inc | 4 | $63 |
| Neuronetics, Inc. | 2 | $51 |
| Adlon Therapeutics L.p. | 3 | $51 |
| Neurocrine Biosciences, Inc. | 2 | $51 |
| Corium, LLC | 2 | $51 |
| Tris Pharma Inc | 2 | $48 |
| Biogen | 2 | $47 |
| Ironshore Pharmaceuticals Inc. | 2 | $45 |
| Avanir Pharmaceuticals, Inc. | 3 | $45 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Alfasigma USA, Inc. | 2 | $34 |
| TMS Neurohealth Centers Inc. | 1 | $33 |
| Alkermes, Inc. | 1 | $28 |
| Almatica Pharma LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,927 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 18 | $642 |
| Lamotrigine | 12 | $200 |
| Clonazepam | 11 | $153 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Chicago
- Yuhwen ChowChicago$8.5M
- Jon GrantChicago$1.4M
- Jeffrey RadoChicago$1.2M
- Mitchell GlaserChicago$1.1M
- Peter WeidenChicago$941K
- Brett PlylerChicago$293K
- Michelle DeesChicago$289K
- Jennifer SpragueChicago$288K
- K Ranga KrishnanChicago$92K
- Pawel DudekChicago$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.